Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Alkem Laboratories Limited maintains 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This activity is distributed across 1 distinct examiner and 1 distinct art unit.
KIM, DANIELLE A is the busiest examiner for the company, accounting for 1 busiest examiner pending action. This figure of 1 matches the total 1 pending office action for the portfolio, indicating that this examiner is the sole point of contact for current office action responses.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, DANIELLE A | 1 | 37.1% | +56.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17997656 | COMBINATION OF ALCAFTADINE AND A CORTICOSTEROID | KIM, DANIELLE A | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17997656 | COMBINATION OF ALCAFTADINE AND A CORTICOSTEROID | KIM, DANIELLE A | 1613 | §103 | Final Rejection | — | Pending | Oct 31, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial